Testing effectiveness (Phase 2)Study completedNCT01770743
What this trial is testing
Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels
Who this might be right for
Anthrax
Emergent BioSolutions 168
Showing 4 of 4 results